Your browser doesn't support javascript.
loading
External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition.
Glehr, Gunther; Riquelme, Paloma; Yang Zhou, Jordi; Cordero, Laura; Schilling, Hannah-Lou; Kapinsky, Michael; Schlitt, Hans J; Geissler, Edward K; Burkhardt, Ralph; Schmidt, Barbara; Haferkamp, Sebastian; Hutchinson, James A; Kronenberg, Katharina.
Afiliação
  • Glehr G; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Riquelme P; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Yang Zhou J; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Cordero L; Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Schilling HL; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Kapinsky M; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Schlitt HJ; Beckman Coulter Life Sciences, Krefeld, Germany.
  • Geissler EK; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Burkhardt R; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Schmidt B; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany.
  • Haferkamp S; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
  • Hutchinson JA; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
  • Kronenberg K; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Front Immunol ; 13: 1011040, 2022.
Article em En | MEDLINE | ID: mdl-36248910

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nivolumabe / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nivolumabe / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suíça